With the help of prescription medications and a whole lot of moisturizing, it’s possible to keep dermatitis under control.

The FDA has cleared an Investigational New Drug Application for Zabalafin Hydrogel, a multi-target therapy for mild to ...

A new study from Huashan Hospital, Shanghai, provided strong evidence supporting the efficacy and safety of abrocitinib for ...

Jason B. Pieper, DVM, MS, DACVD, talks about the multiple therapies available for cases of moderate and severe atopic ...

Nemluvio is now the first approved monoclonal antibody that specifically targets interleukin-31 receptor alpha ...

The AADA continues to increase awareness among employers of the impact skin conditions have on employee health, productivity, ...

Galderma (SWX:GALD) today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic ...

Patients with mild atopic dermatitis who reported nighttime scratching experienced relief when they used an artificial ...

Nemluvio, which was also approved for prurigo nodularis, becomes Galderma’s first approved biologic in its dermatology ...